MindMaze Therapeutics
MindMaze Therapeutics
MindMaze Therapeutics develops innovative neurotherapeutic combinations that integrate behavior, software, devices, and data to improve brain health, recovery and the treatment of neurological disease. Our mission is to deliver precision, evidence-based therapies and digital biomarkers that empower clinicians and patients across clinical and home settings.
We partner with clinical centres and research organisations, run clinical trials, and work on drug development for rare diseases to provide scalable, measurable solutions that accelerate recovery and improve quality of life.
Products & Focus
- MindPod — an immersive platform for motor and cognitive recovery
- MindMotion GO — a behavioral neurorehabilitation system for clinic and home use
- Izar — a smart peripheral for hand motor function rehabilitation
- Physilog — digital motion assessments with 3D motion analytics
Headquarters: Chemin de Roseneck 5, 1006 Lausanne, Switzerland. Contact: [email protected]